Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests
- PMID: 17072588
- DOI: 10.1007/s00213-006-0607-9
Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests
Abstract
Rationale: Premenstrual dysphoric disorder (PMDD) has been assumed to be a subtype of premenstrual syndrome (PMS) with depressive symptoms, such as depressive mood, tension, anxiety, and mood liability during luteal phase. At present, no conclusion has been established about serotonergic function in PMDD.
Objective: The purpose of this study was to investigate the serotonergic function of PMDD subjects in comparison to PMS without PMDD subjects and normal controls via neuroendocrine challenge tests.
Subjects and methods: Twenty-four women (seven with PMDD, eight with PMS without PMDD, and nine normal controls) were tested on three occasions (follicular phase, early luteal phase, and late luteal phase) receiving paroxetine 20 mg orally as a serotonergic probe at 8:00 A: .M: . Plasma ACTH and cortisol were measured prior to the administration and every hour for 6 h thereafter.
Results: As a whole, there were significant differences in serotonergic function measured by ACTH and cortisol responses to paroxetine challenge across these three groups. PMDD subjects showed higher serotonergic function in follicular phase but lower serotonergic function in luteal phase, compared with women with PMS without PMDD and normal controls.
Conclusion: The present findings suggest that PMDD women have fluctuating serotonergic function across their menstrual cycles and that the pattern may be different from PMS without PMDD.
Similar articles
-
Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).Horm Behav. 2008 Jun;54(1):185-93. doi: 10.1016/j.yhbeh.2008.02.018. Epub 2008 Mar 7. Horm Behav. 2008. PMID: 18413151 Free PMC article. Clinical Trial.
-
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.Cochrane Database Syst Rev. 2024 Aug 14;8(8):CD001396. doi: 10.1002/14651858.CD001396.pub4. Cochrane Database Syst Rev. 2024. PMID: 39140320 Review.
-
Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.Psychoneuroendocrinology. 2001 Aug;26(6):551-64. doi: 10.1016/s0306-4530(01)00010-5. Psychoneuroendocrinology. 2001. PMID: 11403977 Clinical Trial.
-
Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.J Clin Psychiatry. 2008 Jun;69(6):991-8. doi: 10.4088/jcp.v69n0616. J Clin Psychiatry. 2008. PMID: 18517289 Clinical Trial.
-
Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. doi: 10.1089/jwh.2006.15.57. J Womens Health (Larchmt). 2006. PMID: 16417420 Review.
Cited by
-
Epidemiological Distribution and Subtype Analysis of Premenstrual Dysphoric Disorder Syndromes and Symptoms Based on TCM Theories.Biomed Res Int. 2017;2017:4595016. doi: 10.1155/2017/4595016. Epub 2017 Jun 15. Biomed Res Int. 2017. PMID: 28698873 Free PMC article. Clinical Trial.
-
Premenstrual symptoms in dysmenorrheic college students: prevalence and relation to vitamin D and parathyroid hormone levels.Int J Environ Res Public Health. 2012 Nov 16;9(11):4210-22. doi: 10.3390/ijerph9114210. Int J Environ Res Public Health. 2012. PMID: 23202842 Free PMC article.
-
Update on research and treatment of premenstrual dysphoric disorder.Harv Rev Psychiatry. 2009;17(2):120-37. doi: 10.1080/10673220902891836. Harv Rev Psychiatry. 2009. PMID: 19373620 Free PMC article. Review.
-
Perceived stress and severity of perimenstrual symptoms: the BioCycle Study.J Womens Health (Larchmt). 2010 May;19(5):959-67. doi: 10.1089/jwh.2009.1717. J Womens Health (Larchmt). 2010. PMID: 20384452 Free PMC article.
-
Biological aspect of hyperthymic temperament: light, sleep, and serotonin.Psychopharmacology (Berl). 2011 Feb;213(2-3):633-8. doi: 10.1007/s00213-010-1999-0. Epub 2010 Aug 28. Psychopharmacology (Berl). 2011. PMID: 20802998
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials